LAWRENCE D. JONES, PH.D.

**** ******** *******

LA JOLLA, CALIFORNIA 92037

HOME: 858-***-****

CELL: 518-***-****

ACADEMIC EXPERIENCE:

1. Professional Advancement Courses:

a. Wharton School: "Finance and Accounting for Non-financial Managers", March 1986.

b. Philip Crosby Associates: “Management Quality College”, March 1987.

2. Ph.D. February 1976: Duke University; Major, Organic Chemistry. Thesis: "Selective Lithiation of Substituted Haloarenes at Low Temperature." Advisor: William E. Parham.

3. Graduate Research Assistant September 1972 - August 1973; Stanford University. Studied isotopic rearrangement of deuterated neopentyl alcohol. Advisor: Harry S. Mosher.

4. B.A. June 1972; Cornell University; Major, Chemistry. Major G.P.A.: 3.6/4.0. Advisor: Martin F. Semmelhack

INDUSTRIAL EXPERIENCE:

CURESCIENCE INSTITUTE MARCH 2020 – PRESENT

• Provide editorial services to the administration and research and development group, including press releases, newspaper essays, etc. Prepare and post blogs on the website regarding topics on various diseases for the layperson to understand. Edit and contribute to numerous scientific articles ranging from COVID-19 to neurodegenerative disorders.

• Prepared two grant applications to NIH (R01) and one application to the Keck Foundation based on the scientific work conducted at CureScience.

LAWRENCE D. JONES & ASSOCIATES LLC JANUARY 2010 - PRESENT

• Founded a consulting firm focusing on the pharmaceutical industry

ARRIS CONSULTANTS LLC JUNE 2005 – DECEMBER 2009

• Co-Founder of an executive recruiting firm that specializes in placing technical personnel in the life sciences industry.

• Annual Income: >$150,000 per year

ALBANY MOLECULAR RESEARCH, INC. January 1999 – January 2005

Position: Senior Vice President, Business Development

• Responsible for marketing to the pharmaceutical and biotechnology industry a suite of fully integrated chemistry disciplines including traditional medicinal chemistry, parallel synthesis, combinatorial chemistry, computational chemistry, cGMP synthesis, analytical chemistry (including methods development and validation), custom synthesis, biocatalysis, fermentation and specialty manufacturing capabilities (high potency suites, controlled substances, cryogenic chemistry).

• Prepared government contract with NIDA with an estimated contract value of $3.0 million. Contract was awarded in December 1999

ALBANY MOLECULAR RESEARCH, INC. March 1998 – January 1999

Position: Vice President, Operations

• Direct and control the Quality, Regulatory and Analytical Departments of the Company. Support R&D through timely analysis and methods development. Develop Analytical Testing and Methods Development business for the company

INHALON PHARMACEUTICALS, INC. August 1991 - February 1998

Position: Executive Vice President, Director, Board Secretary and Co-Founder

• Co-founded generic pharmaceutical company to manufacture, sell and distribute generic inhalation anesthetics and related products to the healthcare market. Inhalon manufactures and sells selected pharmaceuticals to the healthcare market. Participated in securing $15.0 million under two private placements to fund company start-up. Received FDA approval for two drug products within 3 years of original funding. Developed infrastructure for Corporate Administration, Legal and Human Resources

KANEKA AMERICA CORPORATION April 1988 - July 1991

Position: Director of Marketing and Development

• Responsible to the Pharmaceutical Division of Kaneka Corporation (Osaka, Japan) which manufactures and sells chiral pharmaceutical chemical intermediates worldwide. Developed U.S. market for chiral chemical intermediates. Accountable for customer service, advertising and promotion, yearly budgets, and strategic planning. Business Scope: $12.0-15.0 million

.

JOHNSON MATTHEY INC. December 1980 - March 1988

Position: Sales and Marketing Manager. Biomedical Products Group of Chemicals Division manufactures and sells high value, low volume bulk pharmaceuticals in the U.S. market.

• Directed the sales and marketing of bulk pharmaceuticals in the U.S. market. Responsible for profit and loss, negotiating limited liability supply contracts, yearly budgets, and strategic planning. Directed customer service, advertising and promotion. Planned, organized and implemented new product development programs. Business Scope: $4.0-5.0 million

FMC CORPORATION March 1976 - December 1980

Position: Research Chemist. Food and Pharmaceutical Products Division and Industrial Division.

• Developed new aqueous polymeric film-coating dispersion. Aquacoat® launched in September, 1980

• Supervised exploratory product development programs promoting microcrystalline cellulose in the cosmetic and electronics industries as part of business development programs to promote the use of microcrystalline cellulose

• Developed novel anthraquinone derivatives related to the production of hydrogen peroxide

AWARDS, MEMBERSHIPS, ETC.

1. Member of the Board of Directors of Kinentia Biosciences LLC

2. Member of the American Chemical Society, 1971 – 2020.

3. Emeritus Member of the American Chemical Society 2020 – Present.

7. Member of the American Association for the Advancement of Science, 1983 - 1991.

8. Who's Who in the East, Marquis Publications, 1981.

9. Member of Sigma Xi, 1976 - present.

Contact this candidate